Nicole L Park, NP
Nurse Practitioner · Irvine
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 14 years
- University of California, San Francisco School of Medicine, 2012
Offices
1 location · Hasan Badday MD PC · 6 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nicole L Park’s office at (949) 650-1228 to ask if they take your plan before you enroll.
California Medical Board record
Licence G22103 · Cancelled
Licence status: Cancelled · since 1972 · Harvard Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$52,090
Medicare paid this office $52,090 for 114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 69 | $38,301 | $90 |
| New patient visit (45+ min) | 39 | $4,739 | $122 |
| Testing for presence of drug, read by direct observation | 45 | $2,853 | $12 |
| Injection of trigger points, 3 or more muscles | 28 | $2,365 | $45 |
| Aspiration and/or injection of fluid from large joint | 15 | $1,429 | $51 |
Procedures year by year
| Procedure | 2014 | 2015 | 2016 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 28 | 96 | 74 | 23 | 41 | 28 |
| Injection of trigger points, 3 or more muscles | – | – | – | 23 | 66 | 53 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
114 Original Medicare patients in 2024. Average age 73 · Women 51% · Also on Medicaid 28% · Health risk score 1.75. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 39% · Coronary heart disease 35% · Chronic kidney disease 31% · Depression 31% · Atrial fibrillation 25% · COPD 22% · Heart failure 19% · Cancer 18% · Dementia 11% · Stroke 11%.
The office billed $632,540, Medicare allowed $66,900 and paid $52,090; for 961 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 114 | 961 | 73 | 1.75 | $632,540 | $52,090 |
| 2023 | 102 | 1,306 | 70 | 1.91 | $659,240 | $52,731 |
| 2022 | 73 | 378 | 69 | 1.72 | $230,720 | $19,153 |
| 2016 | 47 | 209 | 72 | 0.65 | $68,637 | $15,294 |
| 2015 | 61 | 293 | 74 | 0.74 | $100,648 | $22,613 |
| 2014 | 26 | 92 | 72 | 0.64 | $29,579 | $6,852 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 92 | $39,943 | $90 |
| Testing for presence of drug, read by direct observation | 55 | $3,507 | $12 |
| Injection of trigger points, 3 or more muscles | 37 | $2,743 | $42 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,908 | $47 |
| New patient visit (45+ min) | 13 | $1,459 | $112 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 38 | $8 | $0 |
2022: 4 services
| Return visit (30+ min) | 64 | $14,983 | $95 |
| Injection of trigger points, 3 or more muscles | 19 | $1,068 | $46 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,044 | $45 |
| Testing for presence of drug, read by direct observation | 26 | $704 | $12 |
2016: 3 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 30 | $10,467 | None |
| Aspiration and/or injection of fluid from large joint | 36 | $3,911 | $53 |
| Short return visit (20+ min) | 15 | $700 | $47 |
2015: 4 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 37 | $14,968 | None |
| Aspiration and/or injection of fluid from large joint | 46 | $5,437 | $57 |
| Short return visit (20+ min) | 23 | $1,119 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $70 | None |
2014: 3 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 14 | $4,314 | None |
| Aspiration and/or injection of fluid from large joint | 17 | $1,418 | $51 |
| Short return visit (20+ min) | 11 | $637 | $58 |
Drugs they prescribed that Part D paid
$198,215
Pharmacies billed $198,215 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 59% of their Part D prescriptions (638 of 1,084) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 31% of their opioid prescriptions.
982 generic and 102 brand-name prescriptions · $198,215 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Percocet | 11 | $71,289 | $6,481 |
| Oxycontin | 62 | $45,128 | $728 |
| Oxymorphone Hcl Er | 13 | $11,947 | $919 |
| Linzess | 15 | $8,577 | $572 |
| Fentanyl | 58 | $8,457 | $146 |
See all 23 drugs
| Percocet | 11 | $71,289 | $6,481 |
| Oxycontin | 62 | $45,128 | $728 |
| Oxymorphone Hcl Er | 13 | $11,947 | $919 |
| Linzess | 15 | $8,577 | $572 |
| Fentanyl | 58 | $8,457 | $146 |
| Oxycodone-Acetaminophen | 144 | $7,436 | $52 |
| Movantik | 14 | $6,500 | $464 |
| Hydrocodone-Acetaminophen | 93 | $3,711 | $40 |
| Oxycodone | 126 | $2,365 | $19 |
| Morphine Sulfate Er | 60 | $1,939 | $32 |
| Diclofenac | 14 | $1,813 | $129 |
| Gabapentin | 76 | $1,439 | $19 |
| Pregabalin | 41 | $1,153 | $28 |
| Cyclobenzaprine | 60 | $803 | $13 |
| Ibuprofen | 34 | $381 | $11 |
| Hydromorphone | 43 | $350 | $8 |
| Venlafaxine | 11 | $306 | $28 |
| Ondansetron Odt | 11 | $274 | $25 |
| Tramadol | 16 | $109 | $7 |
| Zolpidem | 12 | $86 | $7 |
| Tizanidine | 26 | $86 | $3 |
| Meloxicam | 12 | $42 | $3 |
| Alprazolam | 23 | $26 | $1 |
Year by year
| 2024 | 1,084 | 76 | 59% (638) | 9% | $198,215 |
| 2023 | 956 | 79 | 61% (584) | 14% | $168,659 |
| 2022 | 1,252 | 187 | 47% (592) | 6% | $65,191 |
| 2016 | 12 | None | None | None | $279 |
| 2015 | 31 | 16 | 48% (15) | 39% | $1,819 |
| 2014 | 32 | 24 | 63% (20) | None | $1,148 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Oxycontin | 53 | $33,413 | $630 |
| Fentanyl | 49 | $14,594 | $298 |
| Oxymorphone Hcl Er | 13 | $10,668 | $821 |
| Linzess | 13 | $9,713 | $747 |
| Buprenorphine | 11 | $4,916 | $447 |
| Oxycodone-Acetaminophen | 110 | $4,405 | $40 |
| Hydrocodone-Acetaminophen | 91 | $3,626 | $40 |
| Oxycodone | 114 | $2,771 | $24 |
| Morphine Sulfate Er | 47 | $2,247 | $48 |
| Pregabalin | 36 | $1,732 | $48 |
| Gabapentin | 51 | $1,125 | $22 |
| Cyclobenzaprine | 54 | $599 | $11 |
| Tramadol | 23 | $529 | $23 |
| Ibuprofen | 33 | $422 | $13 |
| Hydromorphone | 49 | $392 | $8 |
| Tizanidine | 18 | $237 | $13 |
| Methocarbamol | 13 | $126 | $10 |
| Omeprazole | 13 | $97 | $7 |
| Meloxicam | 17 | $51 | $3 |
| Alprazolam | 15 | $44 | $3 |
2022: 24 drugs
| Oxycontin | 14 | $7,797 | $557 |
| Hydrocodone-Acetaminophen | 201 | $5,851 | $29 |
| Fentanyl | 19 | $4,176 | $220 |
| Oxycodone-Acetaminophen | 94 | $3,070 | $33 |
| Pregabalin | 78 | $2,738 | $35 |
| Oxycodone | 69 | $2,608 | $38 |
| Lidocaine | 19 | $2,599 | $137 |
| Gabapentin | 134 | $2,453 | $18 |
| Morphine Sulfate Er | 53 | $1,542 | $29 |
| Diclofenac | 67 | $1,449 | $22 |
| Celecoxib | 34 | $1,126 | $33 |
| Cyclobenzaprine | 68 | $1,072 | $16 |
| Tramadol | 70 | $585 | $8 |
| Ibuprofen | 43 | $405 | $9 |
| Baclofen | 28 | $403 | $14 |
| Hydromorphone | 22 | $388 | $18 |
| Duloxetine | 17 | $360 | $21 |
| Tizanidine | 32 | $346 | $11 |
| Methocarbamol | 11 | $182 | $17 |
| Methadone | 14 | $162 | $12 |
| Trazodone | 16 | $93 | $6 |
| Naproxen | 14 | $88 | $6 |
| Topiramate | 14 | $76 | $5 |
| Meloxicam | 12 | $47 | $4 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 11 | $171 | $16 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 12 | $137 | $11 |
Money from drug and device companies
$192 in 2025
| 2025 | 5 | 7 | None | $192 |
| 2024 | 2 | 7 | None | $154 |
| 2023 | 7 | 23 | None | $1,016 |
| 2022 | 2 | 6 | None | $99 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | Journavx | $82 | 3 payments
|
| DePuy Synthes Sales | Monovisc | $39 | 1 payment
|
| Abbvie | Ubrelvy | $33 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $20 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $18 | 1 payment
|
See all 7 published payments
| Vertex Pharmaceuticals | Meals · 2025-09-27 | None | $21 |
| Abbvie | Meals · 2025-08-14 | Ubrelvy | $33 |
| Vertex Pharmaceuticals | Meals · 2025-05-28 | Journavx | $30 |
| Collegium Pharmaceutical | Meals · 2025-05-08 | Belbuca | $20 |
| Vertex Pharmaceuticals | Meals · 2025-04-23 | Journavx | $30 |
| ConvaTec | Meals · 2025-04-22 | Aquacel Ag+ Extra | $18 |
| DePuy Synthes Sales | Meals · 2025-04-09 | Monovisc | $39 |
See earlier years (2024, 2023, 2022)
2024: $154
| Collegium Pharmaceutical | Belbuca | $132 | 6 payments
|
| Hologic Sales and Service | Novasure | $22 | 1 payment
|
2023: $1,016
| Relievant Medsystems | Intracept | $682 | 9 payments
|
| Collegium Pharmaceutical | Belbuca | $129 | 7 payments
|
| Forte Bio-Pharma | Nalocet | $95 | 3 payments
|
| Hologic Sales and Service | Novasure | $51 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $23 | 1 payment
|
| Vertos Medical | Mild Device Kit | $22 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $14 | 1 payment
|
2022: $99
| Forte Bio-Pharma | Prolate | $79 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $21 | 1 payment
|
Professional record
- NPI
- 1467708198
- Licence
- CA 22103, CA 707298California G22103: Cancelled
- Trained
- University of California, San Francisco School of Medicine, 2012 · 14 years ago
- Group
- Hasan Badday MD PC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2012-07-31
- NPI last updated
- 2016-10-12
This is when the NPI record was last certified, not a medical board exam.